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2 
Abstract 17 
Background: The conventional measurement of obesity utilises the body mass index (BMI) 18 
criterion. Although there are benefits to this method, there is concern that not all individuals at risk 19 
of obesity-associated medical conditions are being identified. Whole-body fat percentage (%FM), 20 
and specifically visceral adipose tissue (VAT) mass, are correlated with and potentially implicated 21 
in disease trajectories, but are not fully accounted for through BMI evaluation. The aims of this 22 
study were (a) to compare five anthropometric predictors of %FM and VAT mass, and (b) to 23 
explore new cut-points for the best of these predictors to improve the characterisation of obesity. 24 
Methods: BMI, waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) 25 
and waist/height0.5 (WHT.5R) were measured and calculated for 81 adults (40 women, 41 men; 26 
mean (SD) age: 38.4 (17.5) years; 94% Caucasian). Total body dual energy X-ray absorptiometry 27 
with Corescan (GE Lunar iDXA, Encore version 15.0) was also performed to quantify %FM and 28 
VAT mass. Linear regression analysis, stratified by sex, was applied to predict both %FM and 29 
VAT mass for each anthropometric variable. Within each sex, we used information theoretic 30 
methods (Akaike Information Criterion; AIC) to compare models. For the best anthropometric 31 
predictor, we derived tentative cut-points for classifying individuals as obese (>25% FM for men 32 
or >35% FM for women, or > highest tertile for VAT mass).  Results: The best predictor of both 33 
%FM and VAT mass in men and women was WHtR. Derived cut-points for predicting whole body 34 
obesity were 0.53 in men and 0.54 in women. The cut-point for predicting visceral obesity was 35 
0.59 in both sexes. Conclusions: In the absence of more objective measures of central obesity 36 
and adiposity, WHtR is a suitable proxy measure in both women and men. The proposed DXA-37 
%FM and VAT mass cut-offs require validation in larger studies, but offer potential for 38 
improvement of obesity characterisation and the identification of individuals who would most 39 
benefit from therapeutic intervention. 40 
Key words: Fat mass; Visceral Fat; Measurement; DXA  41 
3 
Introduction 42 
In clinical practice, public health and the wider health and fitness industry, obesity is 43 
conventionally defined using the body mass index (BMI) criterion, with a value of ≥ 30 kg/m2 44 
categorising both men and women as obese [1]. Although there are many benefits to using BMI, 45 
particularly for population-based screening, evidence indicates the existence of obesity sub-46 
groups such as metabolically healthy but obese, or metabolically unhealthy but normal weight [2, 47 
3]. Therefore, use of BMI only, is potentially falling short of identifying those at an increased risk 48 
of associated conditions, in particular cardio-metabolic diseases. Strong associations have been 49 
identified between whole body and regional fat mass with risk of certain diseases [4], and as such 50 
research indicates that visceral adiposity is an independent predictor of all-cause mortality in men 51 
and women [5, 6]. More recently, greater emphasis has been placed upon the relationships 52 
between visceral adiposity within the abdominal region (visceral adipose tissue; VAT) and 53 
components of metabolic syndrome [7], insulin resistance [8, 9], cardiovascular disease [10, 11] 54 
and even non-spine fractures [12], indicating that VAT is an important target for investigation. 55 
 56 
VAT can be quantified with confidence using imaging modalities such as abdominal computed 57 
tomography (CT). However, due to high radiation exposure and cost implications, CT is not ideal 58 
for large-scale screening or routine practice. However, recent advancements in densitometry 59 
imaging have led to a new Corescan software that enables the quantification of VAT through total 60 
body dual-energy x-ray absorptiometry (DXA) scans, with significantly lower radiation and 61 
expense than CT [13-15]. Although confounded by levels of subcutaneous fat [10], proxy 62 
measures of fat mass, such as BMI, waist circumference (WC) and waist-to-hip ratio (WHR) are 63 
more frequently used [16]. In particular, there is an emerging appreciation of waist-to-height ratio 64 
(WHtR) as a risk indicator for poor cardio-metabolic health [17-23]. Ashwell [24, 25] first devised 65 
the WHtR, proposing that cut-point values of 0.5 and 0.6 can identify individuals who are at 66 
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increased health risk and substantial health risk, respectively. It is important to evidence the 67 
validity of proxy measures of overall and visceral obesity using gold standard criteria, which would 68 
support their use in practice. Roriz et al. [26] performed CT scans in 191 adults and this is the 69 
only study to date that has provided evidence supporting the notion that WHtR is a good predictor 70 
of visceral obesity (defined as >130cm2). These authors proposed WHtR cut-points in 20-59 year 71 
olds of 0.54 in men and 0.59 in women, and 0.55 (men) and 0.58 (women) in participants ≥60 72 
years.  Recently, a new index was proposed – waist/height0.5 – that was a stronger predictor of 73 
cardiometabolic risk than other anthropometric variables, including WHtR, BMI, WC, a body 74 
shape index, and WHR [27].  75 
 76 
There is also growing interest in the clinical utility of multiple anthropometric measures for 77 
identifying individuals at risk of cardiometabolic diseases, but this could be time-consuming, and 78 
not always feasible or realistic in practice.  Research indicates that compared to separate 79 
measures, BMI and WC combined can more accurately predict abdominal fat mass [10]. Similarly, 80 
BMI and WHtR combined, can identify elevated cardiovascular disease risk better than BMI alone 81 
[28].  There have been several studies that have used DXA-derived VAT, although these have 82 
mainly reported on the ability of DXA-VAT to predict cardiometabolic risk and not its utility for 83 
obesity identification [29, 30].  84 
 85 
The current study measured VAT mass and overall fat mass as a percentage of body mass (%FM) 86 
using DXA imaging in UK men and women. The main aims were (a) to compare 5 separate 87 
anthropometric variables in the prediction of %FM and DXA-VAT mass and (b) to identify tentative 88 
new obesity cut-off points for the anthropometric variable in the model found to be the best from 89 
the five candidates.  90 
 91 
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Materials and Methods 92 
Participants and Ethics Approval 93 
As part of a University-wide health screening programme, data from eighty-one adults were 94 
analysed which included a heterogeneous sample of 41 men (mean (SD) age: 40.5 (20) years; 95 
BMI: 26.3 (4.1) kg/m2) and 40 women (age: 36.3 (14.5) years; BMI: 24.8 (4.4) kg/m2). The ethnicity 96 
distribution was 94% Caucasian (n=76), 5% Indian/Pakistani (male n=2; female n=2), and 1% 97 
African-Caribbean (male n=1).  The study was reviewed and approved by the Leeds Beckett 98 
University Research Ethics Committee, and in accordance with the Declaration of Helsinki.  All 99 
participants provided signed informed consent to participate in the study, and all data was 100 
collected between 08:00 am and 12:00 noon during a single visit to the laboratory. 101 
 102 
Anthropometric measurements 103 
Participants were measured wearing light loose clothing or a hospital gown, and no jewellery or 104 
footwear. Body mass was measured using calibrated, digital flat platform scales (Seca Alpha,  105 
SECA, Birmingham, UK) to the nearest 0.1 kg. Standing height was measured to the nearest 0.1 106 
cm using a free-standing stadiometer (SECA, Birmingham, UK) and body mass index (BMI) was 107 
subsequently calculated using the standard Quetelet formula (mass divided by squared height) 108 
(kg/m2) with categories in accordance with the WHO [1] guidelines, more specifically obesity 109 
defined by a BMI ≥30 kg/m2. Waist circumference (WC) was measured at the midway point 110 
between the iliac crest and the lowest rib [31] to the nearest 0.1 cm. Hip circumference (HC) was 111 
measured at the widest part of the buttocks [31] to the nearest 0.1 cm in order to calculate waist-112 
to-hip ratio (WHR) by the simple division of WC/HC. Subsequently, waist to height ratio (WHtR), 113 
a more contemporary measure, was calculated by WC/Height [32]. We also calculated an index 114 
proposed recently as a superior predictor of cardiometabolic risk – WC/Height0.5 (WHT.5R; [27]).  115 
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 116 
DXA-derived measurements 117 
Each participant received one total body fan-beam dual energy X-ray absorptiometry (GE Lunar 118 
iDXA, GE Healthcare, Madison, WI) scan, from which body composition, namely percentage fat 119 
mass (%FM), was determined. VAT was quantified using the validated CoreScan software 120 
(EnCore version 15.0). Participants were placed in the supine position on the scanning table and 121 
the body aligned with the central horizontal axis. Arms were positioned parallel to, but not touching 122 
the body, with a 1 cm space in between the thigh and the hand. Forearms were pronated with 123 
hands flat on the bed. Legs were fully extended and feet were secured with a canvas and Velcro 124 
support to avoid foot movement during the scan acquisition. Scans were conducted using 125 
standard (153 mm/sec) or thick (80 mm/sec) mode depending on body stature. One skilled DXA 126 
technologist led all scans and analyses, which were checked by an International Society for 127 
Clinical Densitometry (ISCD) clinically certified densitometrist. The regions of interest (ROI) for 128 
the total body cut-offs were manually adjusted according to the manufacturer’s instructions. The 129 
ROI over the android region for the assessment of VAT was automated by the software. Precision 130 
error for our Unit has previously been published for both fat mass [33] and VAT mass [15]. The 131 
machine’s calibration was checked and passed on a daily basis using the GE Lunar calibration 132 
hydroxyapatite and epoxy resin phantom. There was no significant drift in calibration for the study 133 
period. 134 
 135 
Data analysis 136 
Linear regression analyses were used to compare five candidate models in the prediction of whole 137 
body fat percentage and VAT mass. The five anthropometric predictors compared were BMI, WC, 138 
WHR, WHtR, and WHT.5R. Diagnostic plots revealed badly behaved residuals for the VAT 139 
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models; therefore, VAT was log-transformed prior to the primary analysis. All analyses were 140 
stratified by sex.  We used an information-theoretic approach (Akaike’s Information Criterion; AIC) 141 
to compare the five candidate models, separately for both whole body fat percentage and VAT 142 
[34]. The model with the lowest AIC identifies the best of the candidate models, and provides a 143 
reference for model comparison. The remaining models are then compared to the best model and 144 
evaluated using the difference in AIC (AICΔ) according to the following scale [35]: Essentially 145 
equivalent model (AICΔ <2), plausible alternative (AICΔ 2-7), weak support (AICΔ 7-14), and 146 
unsupported (AICΔ >14). The AIC identifies the best model of a set of candidates, but its 147 
meaningfulness depends on there being a good predictive model in the set. Therefore, we also 148 
present adjusted R2 and the standard error of the estimate for all models.  149 
 150 
Following the identification of the best model, we used the prediction equation to derive tentative 151 
cut-points for identifying obesity based on %FM and VAT mass. For the %FM equation, standard 152 
thresholds of 25% and 35% were used as the definition of obesity in men and women respectively. 153 
However, due to no known cut-points for VAT mass derived by DXA in males or females, we 154 
generated distributional tertiles whereby the highest third was proposed as the obese group. For 155 
both %FM and VAT mass, we derived the cut-point for the best anthropometric predictor that 156 
resulted in a probability of ≥0.75 (odds of 3:1 in favour) of an individual being obese, as defined 157 
above, given the prediction error from the regression equation (standard error of the estimate; 158 
SEE). To account for the downward bias of the SEE associated with small sample sizes (<50) for 159 
men and women groups, we adjusted the SEE upwards required in the derivation of the cut-160 
points. A probability of ≥0.75 was selected as this is the threshold denoting “likely to be” in the 161 
magnitude-based inferences framework [36]. Briefly, the probability that an individual’s true %FM 162 
or VAT mass value is greater than some threshold value – given the predicted value from a 163 
regression equation - is obtained from the one-tailed area under the t-distribution for the 164 
appropriate degrees of freedom at the following t value: 165 
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 166 
t = (Predicted value minus threshold value for obesity)/standard error of the estimate.  167 
 168 
In small validity studies (n<50), due to sampling variability in the prediction equation, the standard 169 
error of the estimate should ideally be adjusted upwards by a factor given by: 170 
√(1 + 1/n + 1/(n − 3)). Knowing the t-value associated with a probability of 0.75, the threshold 171 
value for obesity, and the standard error of the estimate allows us to derive the required predicted 172 
value. We can then derive the cut-point for the anthropometric predictor by rearranging the 173 
obtained regression equation. A worked example is provided in the Results.  All analyses were 174 
conducted using SPSS Statistics software (v.23, Armonk, NY: IBM Corp). 175 
 176 
Results 177 
Descriptive data for the five anthropometric predictors and the two dependent variables (%FM 178 
and VAT mass) are shown in Table 1.  179 
 180 
Table 1: Sample characteristics  181 
Obesity measure Men 
(n=41) 
Women  
(n=40) 
BMI (kg/m2) 26.2 (4.1) 24.8 (4.4) 
BMI ≥30kg/m2 17% (n=7) 10% (n=4) 
WC (cm) 88.8 (12.3) 78.7 (13.0) 
WHR 0.91 (0.07) 0.80 (0.07) 
WHtR 0.50 (0.07) 0.48 (0.08) 
WHT.5R 0.67 (0.09) 0.61 (0.10) 
Total body fat mass (%) 25.5 (8.4) 34.0 (7.8) 
FM >25% 54% (n=22) - 
FM >35% - 48% (n=19) 
VAT mass (g) 604 ×/÷ 2.9 204 ×/÷ 4.9 
9 
Data presented as Mean (SD)  182 
BMI - Body mass index; WC – waist circumference; WHR – waist-to-hip ratio; WHtR – waist-to-height ratio; 183 
WHT.5R – WC/height0.5; fat mass (FM); visceral adipose tissue (VAT). 184 
For VAT mass, which was log-transformed prior to analysis, the geometric mean is shown, with the 185 
dispersion given as a ×/÷ factor standard deviation (SD) [36]. 186 
 187 
Only around 1 in 6 men and 1 in 10 women were obese according to the BMI criterion versus 188 
around half of each sample according to the whole-body fat percentage thresholds. The 189 
comparison of candidate models for the prediction of %FM (Table 2) and VAT mass (Table 3) 190 
revealed that the WHtR was the best predictor in both men and women.  191 
 192 
Table 2: Prediction of whole body fat percentage from anthropometric measures  193 
 
AIC Difference  
(Inference) 
Adjusted R2 Standard Error of 
Estimate*  
Males (n=41)    
BMI 8 (weak support) 0.71 4.5  
WC 5 (plausible) 0.73 4.4   
WHR 50 (unsupported) 0.19 7.5  
WHtR 0 (best 0.76 4.1  
WHT.5R <1 (equivalent) 0.76 4.1  
Females (n=40)    
BMI 8 (weak support) 0.51 5.5  
WC 6 (plausible) 0.53 5.3  
WHR 27 (unsupported) 0.21 6.9  
WHtR 0 (best) 0.60 5.0 
WHT.5R 2 (plausible) 0.57 5.1 
AIC - Akaike’s Information Criterion; BMI - Body mass index; WC – waist circumference; WHR – waist-to-194 
hip ratio; WHtR – waist-to-height ratio; WHT.5R – WC/height0.5 195 
*The 95% confidence interval for the standard error of the estimate is ×/÷ a factor of 1.25 at these degrees 196 
of freedom. 197 
 198 
 199 
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Table 3: Prediction of VAT mass (Log) from anthropometric measures 200 
 
AIC Difference  
(Inference) 
Adjusted R2 Standard Error of the 
Estimate ×/÷ factor  
(95% CI) 
Males (n=41)    
BMI 13 (weak support) 0.60 2.0 (1.8 to 2.4) 
WC 4 (plausible) 0.68 1.8 (1.6 to 2.1) 
WHR 41 (unsupported) 0.21 2.6 (2.2 to 3.3) 
WHtR 0 (best 0.71 1.8 (1.6 to 2.1)  
WHT.5R <1 (equivalent) 0.71 1.8 (1.6 to 2.1) 
Females (n=32*)    
BMI 6 (plausible) 0.58 2.8 (2.3 to 4.1) 
WC 3 (plausible) 0.61 2.7 (2.2 to 3.7) 
WHR 25 (unsupported) 0.22 4.1 (3.0 to 6.7) 
WHtR 0 (best) 0.65 2.6 (2.2 to 3.7) 
WHT.5R <1 (equivalent) 0.64 2.6 (2.2 to 3.7) 
AIC - Akaike’s Information Criterion; BMI - Body mass index; WC – waist circumference; WHR – waist-to-201 
hip ratio; WHtR – waist-to-height ratio; WHT.5R - WC/height0.5 202 
*8 females excluded due to undetectable levels of VAT mass leading to badly behaved residuals 203 
 204 
The individual cut-point for WHtR associated with a probability of being obese (>25% fat in men 205 
and >35% fat in women) of ≥0.75 was 0.53 in men and 0.54 in women.  Below, as an illustration 206 
of the method, we present the derivation of the male cut-point. The value from the t-distribution 207 
associated with a probability of 0.75 at 39 degrees of freedom (n-2) is 0.681. The standard error 208 
of the estimate from the prediction equation was 4.1% fat (adjusted to 4.2%). From the Methods: 209 
 210 
t = (Predicted value minus threshold value for obesity)/standard error of the estimate.  211 
Therefore, the required predicted value is given by: 212 
Predicted = 25 + 4.2 × 0.681 = 27.9. 213 
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The derived prediction equation was: %FM = 99.7 × WHtR – 24.7. Therefore, the required WHtR 214 
cut-point is given by: (27.9+24.7)/99.7 = 0.53.  215 
 216 
The individual cut-point for WHtR associated with a probability ≥0.75 of being in the highest third 217 
for VAT mass (>1108 g for men and > 477 g for women) was 0.59 in both men and women.  218 
  219 
Discussion  220 
Our main finding is that from five anthropometric variables (BMI, WC and WHR, WHtR, and 221 
WHT.5R) the WHtR is the best predictor of DXA-derived whole body fat percentage and VAT 222 
mass, in both men and women. The new WHT.5R index was an essentially equivalent predictor 223 
of VAT mass in both sexes. For whole body fat percentage, WHT.5R was an equivalent predictor 224 
in males and a plausible alternative in females.    Waist circumference (unadjusted for height) was 225 
a plausible alternative model for both sexes for both outcomes. Models with BMI as the predictor 226 
had weak support for the prediction of whole body fat percentage in both sexes and for VAT mass 227 
in males. However, BMI was a plausible alternative for the prediction of VAT mass in females. 228 
The use of WHR was unsupported in all models. Even for the best model, the R2 and standard 229 
errors of the estimate reveal that simple anthropometric indices are uncertain predictors of DXA-230 
measured body composition outcomes, with prediction errors similar to, if slightly larger, than 231 
those of skinfold methods [37, 38]. 232 
 233 
It is encouraging that WHtR was identified as the best predictor of both whole-body fat percentage 234 
and VAT mass in both men and women, whereas to account for both factors, a clinician would 235 
typically need to measure both BMI and WC, which require differential categorisation by age, sex 236 
and ethnicity that is not required for WHtR [39]. In contrast, in NHANES survey participants, Heo 237 
et al. [40] investigated optimal scaling for both weight and WC to height in the prediction of DXA-238 
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measured total %FM, and reported that WC alone, without adjustment for height, is the optimal 239 
index for both sexes. However, in the current study we found that WHtR was the best model, 240 
although WC was still a plausible alternative. Indeed, WC alone, unadjusted for height, might be 241 
more appealing in the clinical setting as it requires just a single measurement. These findings 242 
highlight that these simple measurements may be used as surrogates, reducing the need for DXA 243 
scans in the clinical setting. 244 
 245 
In the current study, the AIC differences (Tables 2 and 3) revealed that models with WHR as the 246 
predictor were by far the worst of all candidate models, and were unsupported. The rationale 247 
supporting the use of WHR is that it accounts for central and peripheral fat distribution [31], but 248 
changes in WC and hip circumference are relative to each other so favourable weight loss will not 249 
necessarily lead to reductions in WHR. This observation would therefore support that WHR is not 250 
ideal for identification of obesity or monitoring changes in weight status, hence it is not included 251 
in UK National Institute for Health and Care Excellence guidance [41]. Our study indicates that 252 
monitoring WC in absolute terms or in relation to the practically unchanged anthropometric 253 
measure of height is a better surrogate measure for levels of adiposity with the propensity to 254 
cause cardiometabolic diseases. 255 
 256 
Despite the generally well-accepted understanding that BMI has its limitations, it is still valuable 257 
for population-level screening with Ortega and colleagues [42] recently reporting that that BMI 258 
was a better predictor of mortality than fat mass, when determined by hydrostatic weighing or 259 
skinfold thickness, in 60,000 adults. Also, WC - a plausible alternative to WHtR in the current 260 
study - is generally accepted as a proxy for central adiposity, especially as there are well-261 
established risk categories and it is recommended in the UK National Institute for Health and Care 262 
Excellence 2014 guidelines for obesity assessment [41]. Despite this recommendation and the 263 
growing evidence-base in support of waist measurements, emphasis from NICE remains on 264 
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weight and BMI with focus on WC only in those with a BMI under 35 kg/m2. In the current study, 265 
around 1 in 7 participants were classified as obese using the conventional BMI criterion versus 1 266 
in 2 participants using whole-body fat percentage criteria. This observation suggests that sole use 267 
of BMI may be misleading. The finding is underscored by the fact that models with BMI as the 268 
predictor of whole-body fat percentage had weak support in both sexes.   269 
 270 
A second major outcome of our study was identification of obesity cut-off points for WHtR based 271 
on percentage fat mass and VAT mass.  The derived cut-points for whole-body fat percentage 272 
were almost identical in men (0.53) and women (0.54). Moreover, our study is the first to derive a 273 
tentative cut-point for WHtR in the prediction of high DXA-derived VAT mass (defined as the 274 
highest third in our sample distribution, in the absence of an established threshold). Remarkably, 275 
in a cross-sectional study of 191 adults, Roriz et al. [26] reported WHtR cut-points ranging from 276 
0.54 to 0.59 for predicting high visceral adiposity (VAT area of ≥ 130 cm2 determined by CT) in 277 
men and women aged 20-59 years and ≥ 60 years, respectively. Elsewhere, it has been reported 278 
that WHtR is a proxy for visceral adiposity and the existing cut-points of >0.5 and >0.6 are related 279 
to high and very high health risk (obesity and metabolic syndrome) respectively [43]. Our study 280 
differs as we propose cut-off points for visceral adiposity defined arbitrarily as the upper third of 281 
the distribution. Indeed, our proposed 0.59 cut-point aligns closely to Ashwell's 0.6, which is often 282 
referred to as the threshold above which patients should be advised to “take action” based on the 283 
knowledge of visceral fat-associated links with negative health outcomes [5-7, 10, 11]. Our 284 
findings also support Ashwell and Gibson [23] in their proposal that WHtR should be fully 285 
considered as a replacement for the BMI and WC combined matrix, which could support obesity 286 
characterisation when DXA is not available or not desirable.  287 
 288 
Although it is accepted that use of DXA is not feasible in all clinical settings, for those who do 289 
have access we also highlight the advantages of using DXA to obtain important and precise 290 
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information on fat mass and VAT [15, 33], which as an adjunct to WHtR, might further improve 291 
identification of patients at risk of associated negative health outcomes. A prospective study on a 292 
larger scale would enable evaluation of this hypothesis. In this way, an individual participant 293 
exceeding a valid and robust WHtR cut-point could perhaps be used as a simple clinical indicator 294 
for further exploration with more sophisticated methods. This form of risk stratification would 295 
require more research identifying the WHtR cut-points that best ‘rule in’ and ‘rule out’ negative 296 
health outcomes.  297 
 298 
It is well-documented that the number of adults who are defined as obese differs depending on 299 
the measurement method used [44]. Relying, therefore, on just one standard measure of obesity 300 
may lack the required accuracy for the identification of individuals with adiposity at risk of adverse 301 
health outcomes. In an effort to promote the simple public health message of “keep your waist 302 
less than half of your height”, it was recently reported that 10% of the UK population would be 303 
misclassified if only BMI is used, and over one quarter of people with a healthy BMI (18.5-24.9 304 
kg/m2) are misclassified when WHtR >0.5 is implemented [39]. Our results indicate that using BMI 305 
alone classified a much lower number of participants as obese, in comparison to obesity cut-306 
points for measures of WHtR and %FM; this observation cannot be confirmed for visceral obesity 307 
due to the arbitrary nature of our VAT mass classification. Even in a small sample, this is 308 
somewhat alarming and does provide further evidence that alternative measures are fundamental 309 
to the more accurate identification of obesity, therefore ensuring that individuals are referred to 310 
the most suitable therapeutic approach to reduce risk of obesity-related conditions. 311 
 312 
Strengths of our study include the use of precise DXA measures of body composition outcomes, 313 
the use of information-theoretic methods for robust model comparison, and the application of a 314 
novel method to derive cut-points for predicting obesity status. However, it is important to 315 
acknowledge explicitly some key limitations. First, the sample sizes of men and women are small 316 
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for a validity study. We have presented cut-points based on standard errors of the estimate 317 
adjusted for sample size (inflated prediction error resulting from sampling variability) but, 318 
nonetheless, our findings need to be replicated in a large definitive measurement study. Second, 319 
our sample is 94% Caucasian, and our findings cannot be generalised to other ethnic groups.  320 
 321 
Research and Practical implications 322 
Our findings indicate that WHR should not be relied on in clinical practice for obesity identification. 323 
Interestingly, however, in middle-to-older aged adults WHR has been shown to have a greater 324 
predictive ability to identify health outcomes than %FM and BMI [45]. Our study has devised 325 
tentative new cut-off points that need to be validated in a larger sample and could potentially be 326 
utilised in further research and in clinical practice. One key strength of our identified cut-points is 327 
that, despite using different equations for men and women, the generated threshold values are 328 
virtually identical. If replicated, this provides a consistent and simple message to clinicians that 329 
can be transferrable to the general public. The cut-points are more specific but still align broadly 330 
to the WHtR guidance that adults and children should keep WC to less than half their height i.e. 331 
<0.5 [39, 46]. A further advantage of using WHtR is cost effectiveness given that this measure 332 
only requires the use of a tape measure and stadiometer, both of which are inexpensive and 333 
portable. We advise that future prospective research should implement and test these new cut-334 
points to explore associations with negative health outcomes such as cardiometabolic disease, 335 
especially with stratification by obesity phenotypes of metabolically healthy but obese, or 336 
metabolically unhealthy but normal weight, in an effort to increase capture of at-risk individuals.  337 
 338 
In conclusion, our data indicate that in this study WHtR is the best predictor of the five models 339 
compared for obesity characterisation in adults, and in combination with DXA-derived fat mass 340 
and/or VAT mass, the proposed cut-off points might improve obesity identification in both men 341 
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and women. Our results cannot yet be generalised to other population groups but provide new 342 
information which is intended to provide direction for validation and/or exploration in future 343 
studies.  344 
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S1 Table. Sample characteristics.  479 
Data presented as Mean (SD)  480 
BMI - Body mass index; WC – waist circumference; WHR – waist-to-hip ratio; WHtR – waist-to-height ratio; 481 
WHT.5R – WC/height0.5; fat mass (FM); visceral adipose tissue (VAT). 482 
19 
For VAT mass, which was log-transformed prior to analysis, the geometric mean is shown, with the 483 
dispersion given as a ×/÷ factor standard deviation (SD) [36]. 484 
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AIC - Akaike’s Information Criterion; BMI - Body mass index; WC – waist circumference; WHR – waist-to-487 
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